BACKGROUND: Asthmatic patients have a higher susceptibility to rhinovirus (RV) infection, and impaired IFN-β and IFN-λ production has been demonstrated in bronchial epithelial cells from asthmatic adults upon exposure to RV. However, the mechanisms underlying the increased susceptibility of asthmatic patients to RV infection remain poorly understood. The present study aimed to elucidate the characteristics of the immune responses of asthmatic patients' peripheral blood mononuclear cells (PBMCs) to RV exposure. METHODS: PBMCs obtained from 3 different age groups (2-6 years: young-children group; 7-19 years: youth group; ≥20 years: adult group) of asthmatic patients and nonasthmatic control subjects were stimulated with RV-14 for 72 h. Healthy adults with a history of childhood asthma were also enrolled. The concentrations of IFN-α, IL-6, TNF-α, IL-10, and soluble Fas ligand (sFasL) in the culture supernatants were measured by ELISA. RESULTS: When compared with age-matched control subjects, IFN-α production was significantly lower in the asthmatic youth group. IL-6, TNF-α, IL-10, and sFasL productions were significantly lower in both the asthmatic youth group and the adult group. Such impaired responses were not found in healthy adults with a history of childhood asthma. No significantly different responses were found between the asthmatics and controls in the young-children group, whereas young asthmatic children with persistent wheeze during a 2-year follow-up showed significantly lower IL-10 production than those without wheeze. CONCLUSIONS: These results imply the involvement of impaired production of both IFN-α and inflammatory cytokines seen in asthmatic patients' PBMCs upon exposure to RV in the higher susceptibility of those patients to RV infection.
BACKGROUND: Asthmatic patients have a higher susceptibility to rhinovirus (RV) infection, and impaired IFN-β and IFN-λ production has been demonstrated in bronchial epithelial cells from asthmatic adults upon exposure to RV. However, the mechanisms underlying the increased susceptibility of asthmatic patients to RV infection remain poorly understood. The present study aimed to elucidate the characteristics of the immune responses of asthmatic patients' peripheral blood mononuclear cells (PBMCs) to RV exposure. METHODS: PBMCs obtained from 3 different age groups (2-6 years: young-children group; 7-19 years: youth group; ≥20 years: adult group) of asthmatic patients and nonasthmatic control subjects were stimulated with RV-14 for 72 h. Healthy adults with a history of childhood asthma were also enrolled. The concentrations of IFN-α, IL-6, TNF-α, IL-10, and soluble Fas ligand (sFasL) in the culture supernatants were measured by ELISA. RESULTS: When compared with age-matched control subjects, IFN-α production was significantly lower in the asthmatic youth group. IL-6, TNF-α, IL-10, and sFasL productions were significantly lower in both the asthmatic youth group and the adult group. Such impaired responses were not found in healthy adults with a history of childhood asthma. No significantly different responses were found between the asthmatics and controls in the young-children group, whereas young asthmatic children with persistent wheeze during a 2-year follow-up showed significantly lower IL-10 production than those without wheeze. CONCLUSIONS: These results imply the involvement of impaired production of both IFN-α and inflammatory cytokines seen in asthmatic patients' PBMCs upon exposure to RV in the higher susceptibility of those patients to RV infection.
Authors: Dhara A Patel; Yingjian You; Guangming Huang; Derek E Byers; Hyun Jik Kim; Eugene Agapov; Martin L Moore; R Stokes Peebles; Mario Castro; Kaharu Sumino; Adrian Shifren; Steven L Brody; Michael J Holtzman Journal: J Allergy Clin Immunol Date: 2014-09-09 Impact factor: 10.793
Authors: Annemarie Sykes; Michael R Edwards; Jonathan Macintyre; Ajerico Del Rosario; Vera Gielen; Jennifer Haas; Onn Min Kon; Mark McHale; Sebastian L Johnston Journal: PLoS One Date: 2013-06-18 Impact factor: 3.240
Authors: Vera Gielen; Annemarie Sykes; Jie Zhu; Brian Chan; Jonathan Macintyre; Nicolas Regamey; Elisabeth Kieninger; Atul Gupta; Amelia Shoemark; Cara Bossley; Jane Davies; Sejal Saglani; Patrick Walker; Sandra E Nicholson; Alexander H Dalpke; Onn-Min Kon; Andrew Bush; Sebastian L Johnston; Michael R Edwards Journal: J Allergy Clin Immunol Date: 2015-01-25 Impact factor: 10.793
Authors: Hitasha Rupani; Rocio T Martinez-Nunez; Patrick Dennison; Laurie C K Lau; Nivenka Jayasekera; Tom Havelock; Ana S Francisco-Garcia; Christopher Grainge; Peter H Howarth; Tilman Sanchez-Elsner Journal: Am J Respir Crit Care Med Date: 2016-07-01 Impact factor: 21.405
Authors: Banafshe Hosseini; Bronwyn S Berthon; Malcolm R Starkey; Adam Collison; Rebecca F McLoughlin; Evan J Williams; Kristy Nichol; Peter Ab Wark; Megan E Jensen; Carla Rebeca Da Silva Sena; Katherine J Baines; Joerg Mattes; Lisa G Wood Journal: Front Immunol Date: 2021-06-17 Impact factor: 7.561
Authors: M R Edwards; N Regamey; M Vareille; E Kieninger; A Gupta; A Shoemark; S Saglani; A Sykes; J Macintyre; J Davies; C Bossley; A Bush; S L Johnston Journal: Mucosal Immunol Date: 2012-12-05 Impact factor: 7.313